Libo Pharma Corp. (TPEX:7888)
Taiwan · Delayed Price · Currency is TWD 25.40
-1.00 (-3.79%)
At close: Nov 6, 2026
Libo Pharma Market Cap
Libo Pharma has a market cap or net worth of 1.91 billion as of November 6, 2026. It is the 28,640th most valuable company in the world and the 1,631st biggest in Taiwan.
Market Cap
1.91B
Enterprise Value
1.27B
Revenue
n/a
Global Rank
Country Rank
#1,631 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since December 23, 2025, Libo Pharma's market cap has decreased from 3.55B to 1.91B, a decrease of -46.13%. That is a compound annual growth rate of -50.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 1.91B | -48.37% |
| Dec 31, 2025 | 3.70B | 4.35% |
| Dec 23, 2025 | 3.55B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Taho Pharmaceuticals | 12.34B |
| Pharmasaga | 6.32B |
| TEH SENG Pharmaceutical Mfg. | 2.24B |
| Protect Animal Health | 2.23B |
| Timing Pharmaceutial | 1.69B |
| Gin Hwa Biotech Incorporation | 1.61B |
| Anbogen Therapeutics | 1.54B |
| Anya Biopharm | 1.29B |